Free Trial
NASDAQ:DXR

Daxor (DXR) Stock Price, News & Analysis

Daxor logo
$7.45 -0.19 (-2.49%)
As of 04/7/2025 03:58 PM Eastern

About Daxor Stock (NASDAQ:DXR)

Key Stats

Today's Range
$7.23
$7.56
50-Day Range
$7.05
$8.39
52-Week Range
$6.55
$10.00
Volume
3,899 shs
Average Volume
7,252 shs
Market Capitalization
$36.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.00
Consensus Rating
Buy

Company Overview

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Remove Ads

Daxor Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

DXR MarketRank™: 

Daxor scored higher than 63% of companies evaluated by MarketBeat, and ranked 323rd out of 901 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Daxor has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Daxor has only been the subject of 1 research reports in the past 90 days.

  • Read more about Daxor's stock forecast and price target.
    • Percentage of Shares Shorted

      0.64% of the float of Daxor has been sold short.
    • Short Interest Ratio / Days to Cover

      Daxor has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Daxor has recently increased by 12.17%, indicating that investor sentiment is decreasing significantly.
    • Percentage of Shares Shorted

      0.64% of the float of Daxor has been sold short.
    • Short Interest Ratio / Days to Cover

      Daxor has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Daxor has recently increased by 12.17%, indicating that investor sentiment is decreasing significantly.
    • News Coverage This Week

      MarketBeat has tracked 3 news articles for Daxor this week, compared to 0 articles on an average week.
    • MarketBeat Follows

      1 people have added Daxor to their MarketBeat watchlist in the last 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Daxor insiders have bought more of their company's stock than they have sold. Specifically, they have bought $50,082.00 in company stock and sold $0.00 in company stock.

    • Percentage Held by Insiders

      59.00% of the stock of Daxor is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 1.34% of the stock of Daxor is held by institutions.

    • Read more about Daxor's insider trading history.
    Receive DXR Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Daxor and its competitors with MarketBeat's FREE daily newsletter.

    DXR Stock News Headlines

    Daxor Co. (NASDAQ:DXR) CEO Buys $25,804.80 in Stock
    Daxor announces new data from Duke University on BVA at ACC
    DOGE Social Security bombshell?
    Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
    See More Headlines

    DXR Stock Analysis - Frequently Asked Questions

    Daxor's stock was trading at $7.69 at the beginning of 2025. Since then, DXR shares have decreased by 3.1% and is now trading at $7.45.
    View the best growth stocks for 2025 here
    .

    Shares of DXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Daxor investors own include Merck & Co., Inc. (MRK), Novavax (NVAX), Arbutus Biopharma (ABUS), Abbott Laboratories (ABT), Abiomed (ABMD), Aclaris Therapeutics (ACRS) and

    Company Calendar

    Today
    4/08/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Surgical & medical instruments
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:DXR
    Employees
    37
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $25.00
    High Stock Price Target
    $25.00
    Low Stock Price Target
    $25.00
    Potential Upside/Downside
    +235.6%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $2.13 million
    Price / Cash Flow
    N/A
    Price / Book
    N/A

    Miscellaneous

    Free Float
    1,983,000
    Market Cap
    $36.04 million
    Optionable
    Not Optionable
    Beta
    -0.06
    These 7 Stocks Will Be Magnificent in 2025 Cover

    Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

    Get This Free Report

    This page (NASDAQ:DXR) was last updated on 4/8/2025 by MarketBeat.com Staff
    From Our Partners